N-Nitroso Binimetinib

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

N-Nitroso Binimetinib is a nitroso impurity that can form during the synthesis, storage, or degradation of binimetinib, a MEK inhibitor used in cancer therapy. Its applications are focused on pharmaceutical quality and safety: it is used in impurity profiling to detect and quantify trace N-nitroso compounds, and to ensure regulatory compliance with guidelines for potential genotoxic impurities in drug products.

Head Office Address

Our Office Addresses